[18F]FP-R01-MG-F2

DRUG2 trials

Sponsors

Stanford University

Conditions

Covid19 PneumoniaHealthy SubjectIdiopathic Pulmonary FibrosisPancreatic CarcinomaPrimary Sclerosing Cholangitis

Early Phase 1

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

CompletedNCT02683824

Stanford UniversityHealthy Subject, Pancreatic Carcinoma

Start: 2016-01-12End: 2022-12-01Updated: 2023-09-21

Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT

CompletedNCT03183570

Stanford UniversityCovid19 Pneumonia, Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis

Start: 2017-11-08End: 2025-01-25Updated: 2025-02-04

Related Papers

Pilot-phase PET/CT study targeting integrin α<sub>v</sub>β<sub>6</sub> in pancreatic cancer patients using the cystine-knot peptide-based <sup>18</sup>F-FP-R<sub>0</sub>1-MG-F2.

2021-11-0312 citations